Befejeződött1. fázis
Phase 1b study investigating the association of NP137 with mFOLFIRINOX in locally advanced pancreatic ductal adenocarcinoma LAP NET 1
Key facts
- Where
- Bobigny, Grenoble Cedex 9, Lille Cedex, Lyon, Pessac, Poitiers, Reims Cedex, Rennes Cedex 9 és Saint-Priest-en-Jarez, FranciaországSee the 10 sites
- Phase
- 1. fázis
Where in Franciaország
- Assistance Publique Hopitaux De ParisBobigny, FranciaországNo longer taking part
- Centre Hospitalier Universitaire Grenoble AlpesGrenoble Cedex 9, FranciaországNo longer taking part
- CHU LilleLille Cedex, FranciaországNo longer taking part
- Centre Leon BerardLyon, FranciaországNo longer taking part
- Hôpital Privé Jean MermozLyon, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de BordeauxPessac, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de PoitiersPoitiers, FranciaországNo longer taking part
- Centre Hospitalier Universitaire De ReimsReims Cedex, FranciaországNo longer taking part
- Centre Hospitalier Universitaire De RennesRennes Cedex 9, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de Saint EtienneSaint-Priest-en-Jarez, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Grenoble
- Trial code
- EU 2022-500905-42-00
- Record updated
- 2025. április 8.